Investor Presentaiton slide image

Investor Presentaiton

Shield is poised to be a blockbuster diagnostic brand 2024 FDA approval Medicare reimbursement shield™ GUARDANT™ 2026 USPSTF Guidelines 2028 >1M tests >$500M revenue Highly efficient S&M spend Significant economies of scale as volume grows INVESTOR 20 DAY 23 150
View entire presentation